Mosche Pompsch
Essen, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacks.
Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacks.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: August 19, 2024
Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGAD.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: August 02, 2024
Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Diseases: COPANMO(G)-Study.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: September 16, 2022
Microembolic signals and antiplatelet therapy in Moyamoya angiopathy.
Journal: Journal of neurology
Published: July 17, 2022
Evidence of extensive cellular immune response after SARS-CoV-2 vaccination in ocrelizumab-treated patients with multiple sclerosis.
Journal: Neurological research and practice
Published: September 19, 2021
Autophagy induced by ionizing radiation promotes cell death over survival in human colorectal cancer cells.
Journal: Experimental cell research
Published: July 12, 2018
PDI is an essential redox-sensitive activator of PERK during the unfolded protein response (UPR).
Journal: Cell death & disease
Published: February 10, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026